Josef Novák

689 total citations
25 papers, 567 citations indexed

About

Josef Novák is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Josef Novák has authored 25 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Josef Novák's work include Virus-based gene therapy research (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Protease and Inhibitor Mechanisms (3 papers). Josef Novák is often cited by papers focused on Virus-based gene therapy research (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Protease and Inhibitor Mechanisms (3 papers). Josef Novák collaborates with scholars based in United States, Czechia and Japan. Josef Novák's co-authors include James H. McMaster, Phil G. Campbell, Nalini Chandar, Satoru K. Nishimoto, John D. Hayes, Paola Cassoni, Václav Vopálenský, Martin Pospíšek, Martin L. Smith and Marie C. Pizzorno and has published in prestigious journals such as PLoS ONE, Scientific Reports and Endocrinology.

In The Last Decade

Josef Novák

25 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Josef Novák United States 12 289 139 119 115 60 25 567
A.A. Geldof Netherlands 15 211 0.7× 200 1.4× 64 0.5× 76 0.7× 51 0.8× 39 638
Leonid L. Nikitenko United Kingdom 16 416 1.4× 248 1.8× 157 1.3× 50 0.4× 34 0.6× 22 801
Jouko Oikarinen Finland 15 451 1.6× 59 0.4× 68 0.6× 71 0.6× 150 2.5× 32 787
D O Lucas United States 10 336 1.2× 107 0.8× 77 0.6× 57 0.5× 58 1.0× 17 740
Katrina L. Watson Canada 11 300 1.0× 172 1.2× 226 1.9× 38 0.3× 81 1.4× 18 642
Shiho Kodama Japan 12 253 0.9× 102 0.7× 73 0.6× 21 0.2× 25 0.4× 17 569
T.J. Martin United States 6 628 2.2× 350 2.5× 78 0.7× 68 0.6× 199 3.3× 13 878
Jennifer L. Brockman United States 11 432 1.5× 251 1.8× 63 0.5× 91 0.8× 122 2.0× 13 683
Pasi Nokelainen Finland 12 269 0.9× 63 0.5× 94 0.8× 352 3.1× 359 6.0× 12 787
Peiguo Ding China 12 443 1.5× 248 1.8× 95 0.8× 22 0.2× 60 1.0× 17 819

Countries citing papers authored by Josef Novák

Since Specialization
Citations

This map shows the geographic impact of Josef Novák's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josef Novák with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josef Novák more than expected).

Fields of papers citing papers by Josef Novák

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josef Novák. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josef Novák. The network helps show where Josef Novák may publish in the future.

Co-authorship network of co-authors of Josef Novák

This figure shows the co-authorship network connecting the top 25 collaborators of Josef Novák. A scholar is included among the top collaborators of Josef Novák based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josef Novák. Josef Novák is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Váňová, Tereza, Josef Novák, Tomáš Buryška, et al.. (2024). A closed 3D printed microfluidic device for automated growth and differentiation of cerebral organoids from single‐cell suspension. Biotechnology Journal. 19(8). e2400240–e2400240. 6 indexed citations
2.
Novák, Josef, Soňa Hubáčková, Martin Mistrík, et al.. (2023). Topological stress triggers persistent DNA lesions in ribosomal DNA with ensuing formation of PML-nucleolar compartment. eLife. 12. 1 indexed citations
3.
Chrienová, Žofia, Patrik Olekšák, Marek Bajda, et al.. (2022). Discovery of small molecule mechanistic target of rapamycin inhibitors as anti-aging and anti-cancer therapeutics. Frontiers in Aging Neuroscience. 14. 1048260–1048260. 13 indexed citations
4.
Novák, Josef, et al.. (2020). Interleukin-1α associates with the tumor suppressor p53 following DNA damage. Scientific Reports. 10(1). 6995–6995. 2 indexed citations
5.
Novák, Josef, Václav Vopálenský, Martin Pospíšek, & Anni Vedeler. (2020). Co-localization of Interleukin-1α and Annexin A2 at the plasma membrane in response to oxidative stress. Cytokine. 133. 155141–155141. 4 indexed citations
6.
Pospíšek, Martin, et al.. (2018). Transcription apparatus of the yeast virus-like elements: Architecture, function, and evolutionary origin. PLoS Pathogens. 14(10). e1007377–e1007377. 9 indexed citations
8.
Kinsey, Conan G., Gianni Bussolati, Martino Bosco, et al.. (2007). Constitutive and ligand‐induced nuclear localization of oxytocin receptor. Journal of Cellular and Molecular Medicine. 11(1). 96–110. 40 indexed citations
9.
Novák, Josef, et al.. (2005). Proenzyme therapy of cancer.. PubMed. 25(2A). 1157–77. 33 indexed citations
10.
Takahashi, M., et al.. (2002). Transformation of MC3T3-E1 cells following stress and transfection with pSV2neo plasmid.. PubMed. 22(2A). 585–98. 1 indexed citations
11.
Novák, Josef, M. B. Judkins, Mitch Chernin, et al.. (2000). A plasmin-derived hexapeptide from the carboxyl end of osteocalcin counteracts oxytocin-mediated growth inhibition [corrected] of osteosarcoma cells.. PubMed. 60(13). 3470–6. 29 indexed citations
12.
Campbell, Phil G., et al.. (1994). Binding and activation of plasminogen on the surface of osteosarcoma cells. Journal of Cellular Physiology. 159(1). 1–10. 17 indexed citations
13.
Chandar, Nalini, Phil G. Campbell, Josef Novák, Martin L. Smith, & Martin L. Smith. (1993). Dependence of induction of osteocalcin gene expression on the presence of wild‐type p53 in a murine osteosarcoma cell line. Molecular Carcinogenesis. 8(4). 299–305. 17 indexed citations
14.
Campbell, Phil G., et al.. (1992). Involvement of the plasmin system in dissociation of the insulin-like growth factor-binding protein complex.. Endocrinology. 130(3). 1401–1412. 117 indexed citations
15.
Chandar, Nalini, et al.. (1992). Inactivation of p53 gene in human and murine osteosarcoma cells. British Journal of Cancer. 65(2). 208–214. 140 indexed citations
16.
Novák, Josef, Phil G. Campbell, & Nalini Chandar. (1992). Plasminogen activator-mediated cell-surface activation of transforming growth factor-beta in normal and neoplastic osteoblasts. Bone and Mineral. 17. 203–203. 1 indexed citations
17.
Campbell, Phil G. & Josef Novák. (1991). Insulin‐Like growth factor binding protein (IGFBP) inhibits igf action on human osteosarcoma cells. Journal of Cellular Physiology. 149(2). 293–300. 50 indexed citations
18.
Beidler, David, et al.. (1989). Resistance to pyrazofurin and 6-azauridine in normal MC3T3-E1 murine osteoblasts. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1014(2). 101–107. 1 indexed citations
19.
Novák, Josef, et al.. (1983). Bone resorption in osteogenic sarcoma. I. Release of calcium by tumor cells, normal fibroblasts, and macrophages.. PubMed. 268–77. 2 indexed citations
20.
Novák, Josef & Arthur W. Galston. (1971). Studies on auxin protector substances, IAA-oxidase and peroxidase in cotyledons of Pharbitis nil. Plant and Cell Physiology. 12(6). 931–940. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026